Hanchung Medical announced its participation in InterCHARM Korea 2023, a leading beauty and cosmetics exhibition held from August 30 to September 1 at COEX Convention Center in Seoul, South Korea.

InterCHARM Korea is an annual exhibition that attracts more than 3,000 overseas buyers from over 50 countries each year. The event has established itself as a major business platform in the beauty and cosmetics industry by connecting global buyers with key players and emerging markets.

At the exhibition, Hanchung Medical showcased its Bonetta HA Filler, a product recognized for its safety through minimized BDDE residue and long-lasting viscoelasticity. The company also presented its skin regeneration solutions, Bijunel Cellovero and Bijunel Rejuvero, which are formulated with the three core elements of skin regeneration. These products received strong interest from buyers visiting the exhibition.

According to the company, Bijunel products have already been registered with CPNP in Europe and approved by NMPA in China. Hanchung Medical has scheduled follow-up meetings with multiple buyers and plans to continue expanding into Southeast Asia and European markets in the future.